Core Viewpoint - Hims & Hers Health Inc. is under investigation for potential securities fraud related to misleading statements made to investors during a specified Class Period [1][2]. Group 1: Investigation Details - Berger Montague is investigating whether Hims & Hers violated federal securities laws by making false or misleading statements during the Class Period from April 29, 2025, to June 22, 2025 [1]. - Following the termination of a partnership with Novo Nordisk due to unauthorized marketing and sale of compounded semaglutide drugs, Hims & Hers' shares dropped over 34% on June 23, 2025 [2]. - A complaint has been filed alleging material misstatements and omissions in violation of federal securities laws [2]. Group 2: Legal Action - Investors have until August 25, 2025, to seek appointment as lead plaintiff in the class action lawsuit, which allows them to direct the case and advocate for other harmed investors [3].

Core Points - The Ordinary Annual General Meeting of Equasens Group was held on June 25, 2025, with a quorum of 88.83% of shares with voting rights present [1] - The meeting approved the separate parent company and consolidated financial statements for the 2024 financial year [1] Voting Results Summary - **Resolution One**: Approval of the annual financial statements received 13,170,684 votes in favor, with no votes against and 2,441 abstentions [1] - **Resolution Two**: Discharge of directors and Statutory Auditors received 12,831,312 votes in favor, 339,266 votes against, and 2,547 abstentions [1] - **Resolution Three**: Approval of the consolidated financial statements received 13,170,684 votes in favor, with no votes against and 2,441 abstentions [1] - **Resolution Four**: Appropriation of earnings and setting the dividend received 13,138,631 votes in favor, 34,494 votes against [1] - **Resolution Five**: Agreements and commitments under Articles L. 225-38 received 13,101,211 votes in favor, 59,549 votes against, and 12,365 abstentions [2] - **Resolution Six**: Approval of compensation information for corporate officers received 12,507,815 votes in favor, 665,242 votes against, and 68 abstentions [2] - **Resolution Seven**: Approval of compensation for Mr. Thierry Chapusot received 13,115,547 votes in favor, 57,510 votes against, and 68 abstentions [2] - **Resolution Eight**: Approval of compensation for Mr. Denis Supplisson received 10,782,118 votes in favor, 2,390,939 votes against, and 68 abstentions [2] - **Resolution Nine**: Approval of compensation for Mr. Grégoire de Rotalier received 10,782,118 votes in favor, 2,390,939 votes against, and 68 abstentions [2] - **Resolution Ten**: Approval of compensation for Mr. Damien Valicon received 10,762,253 votes in favor, 2,410,804 votes against, and 68 abstentions [2] - **Resolution Eleven**: Approval of the compensation policy for Mr. Thierry Chapusot for 2025 received 13,115,547 votes in favor, 57,510 votes against, and 68 abstentions [3] - **Resolution Twelve**: Approval of the compensation policy for Mr. Denis Supplisson for 2025 received 10,545,572 votes in favor, 2,454,875 votes against [3] - **Resolution Thirteen**: Approval of the compensation policy for Mr. Grégoire de Rotalier for 2025 received 10,537,207 votes in favor, 2,463,240 votes against, and 172,678 abstentions [3] - **Resolution Fourteen**: Approval of the compensation policy for Mr. Damien Valicon for 2025 received 10,537,207 votes in favor, 2,463,240 votes against, and 172,678 abstentions [3] - **Resolution Fifteen**: Approval of the compensation policy for Directors received 13,127,845 votes in favor, 45,212 votes against, and 68 abstentions [3] - **Resolution Sixteen**: Setting total annual compensation for Directors for 2025 received 13,127,845 votes in favor, 45,212 votes against, and 68 abstentions [3] - **Resolution Seventeen**: Authorization to repurchase own shares received 11,297,178 votes in favor, 1,875,947 votes against [3] - **Resolution Eighteen**: Powers for formalities received 13,173,125 votes in favor, with no votes against or abstentions [3] Company Overview - Equasens Group, a leader in digital healthcare solutions, employs over 1,300 people across Europe and has been in operation for over 35 years [4][5] - The company specializes in providing applications that support healthcare professionals, including electronic equipment, digital solutions, and healthcare robotics [5][6] - Equasens Group is listed on Euronext Paris and included in various indexes such as MSCI GLOBAL SMALL CAP and CAC SMALL [7]

Market Overview - The first half of 2025 experienced increased volatility and uncertainty due to President Trump's tariffs and a faster-than-expected cooling of inflation, leading to market recovery [1] - Recent months have shown favorable market conditions with easing trade tensions and a reduction in the Middle East crisis [1] Stock Performance and Recommendations - Optimism regarding artificial intelligence is expected to continue supporting stock prices, particularly in technology sectors [2] - Cooling inflation raises expectations for potential rate cuts starting in September 2025, contributing to a positive market outlook [2] - Stocks such as Cracker Barrel Old Country Store (CBRL), BGSF, ArcBest Corporation (ARCB), Cardinal Health (CAH), and AutoNation (AN) are recommended for monitoring as the second half of 2025 begins [2][6] Screening Strategy - A screening strategy has been developed to identify stocks based on improving broker recommendations and upward revisions in earnings estimates over the past four weeks [3] - The price/sales ratio is included as a valuation metric, focusing on companies with strong top-line performance [3] Screening Criteria - The top 75 companies with net upgrades in broker ratings over the last four weeks are identified [4] - The top 10 stocks with the highest percentage change in earnings estimates for the upcoming quarter are highlighted [4] - Companies in the bottom 10% of price-to-sales ratios are included for better valuation [4] Company Highlights - Cracker Barrel is focusing on menu innovation and pricing strategies to drive growth, introducing new offerings to attract customers [5] - BGSF has seen a 25% increase in shares over the past month and has a Zacks Rank 1, with earnings estimates rising over 300% in the last 60 days [7] - ArcBest is improving productivity and service quality, expecting a 52.1% increase in earnings per share for 2026 compared to 2025 [8] - Cardinal Health is undergoing strategic improvements to revitalize its business model, with its Medical segment expected to drive growth [9][10] - AutoNation's diversified product portfolio and strategic acquisitions support its market position, currently holding a Zacks Rank 3 [11]

Study highlights how AI tools like ChatGPT are shaping reputation and consumer perception of leading OTC brandsCAMPBELL, Calif. and NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Campbell, California and New York City – July 1st, 2025 – LiveWorld, Inc. (OTC Markets: LVWD), a pioneer in social-first digital engagement and integrated human-AI solutions, today announced the release of the first-ever AI Brand Reputation Index for over-the-counter (OTC) consumer healthcare brands. The groundbreaking study delivers ...

Core Insights - TeleVox has launched the Planned Outreach Program to enhance patient engagement for small practices, addressing the outreach gap in patient care [1][3] - The TeleVox Practice Edition platform has been recognized as the "Best Practice Management Solution" in the MedTech Breakthrough Awards, showcasing its effectiveness in improving healthcare delivery [1][5] Product Features - The Planned Outreach Program includes prebuilt, specialty-specific campaigns and templates for seasonal and recurring care needs, allowing practices to proactively plan outreach [2] - Features such as the Annual Campaign Planning and Smart List Builder facilitate targeted communication by leveraging past appointment data and patient contact lists [2] - Communication can be delivered via SMS or IVR, ensuring convenience for patients, while follow-up features help re-engage non-responsive patients [2] Market Impact - The Planned Outreach Program aims to democratize access to advanced engagement technology for small practices, enabling them to provide proactive care similar to larger health systems [3] - By improving patient follow-up care, such as vaccinations and annual checkups, the program is expected to enhance patient health outcomes and increase practice revenue [3] - The platform reduces manual tasks for staff, improving operational efficiency and allowing for a more personalized patient care experience [3] Company Background - TeleVox is part of WestCX within West Technology Group and has been recognized for its innovation in digital patient relationship management [5] - The company serves over 7,000 healthcare organizations, including hospitals and community health centers, focusing on effective patient engagement and communication [5] - TeleVox integrates its solutions with electronic health records (EHR) to support automated, personalized interactions with patients [5]

Core Points - CareCloud has surpassed the accelerated filer threshold with a public float of $85.1 million as of June 30, 2025, triggering new compliance requirements under SEC regulations [1] - The achievement is seen as a validation of CareCloud's growth trajectory and investor confidence, with a commitment to compliance and corporate governance emphasized by the Co-CEO [2] - The current audit firm cannot perform the required ICFR attestation, necessitating a change in auditors to ensure compliance [2] - CareCloud has initiated a process to engage a new audit firm capable of fulfilling the necessary services for fiscal year 2025 [3] Company Overview - CareCloud specializes in AI-driven healthcare technology solutions, helping over 40,000 providers enhance patient care while reducing administrative burdens and operating costs [4]

UnitedHealth Group and Memorial Sloan Kettering Cancer Center are locked in a contract standoff that threatens to interrupt treatment for thousands of cancer patients in the New York area https://t.co/ofM1JnhWVV ...

This Startup Built A Hospital In India To Test Its AI Software.https://t.co/8eWJDPE9ID https://t.co/pXG0XV1ZB0 ...

Shares of Apollo Hospitals, India’s largest healthcare services firm, surged to a record Tuesday after it announced plans to merge its digital health and pharmacy businesses and spin them off as a new listed entity https://t.co/OsN2L4Xz4M ...

ab 27 June 2025 Global Research China Healthcare Expert call takeaways: JDH, a rising competitor in drug retail O2O Meituan: a clear leader in drug retail O2O We invited an ex-Meituan manager of the drug retail business to discuss the pharmaceutical retail O2O (online-to-offline, or quick-commerce) market. According to the expert, Meituan was one of the first to start the O2O business in 2013 and is now China's largest O2O provider owing to its delivery capability and dispatch system advantages. To expand o ...